Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | %Female (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Bulletin of Faculty of Pharmacy, Cairo University | journal | 3.075 Q1 | 1 | 0 | 1 | 0 | 18 | 1 | 0.00 | 0.00 | 0.00 | |
2 | Journal of Immunology Research | journal | 1.352 Q1 | 113 | 222 | 794 | 12697 | 2852 | 760 | 3.37 | 57.19 | 46.98 | |
3 | Current Neuropharmacology | journal | 1.210 Q1 | 103 | 83 | 241 | 9247 | 912 | 213 | 3.28 | 111.41 | 40.82 | |
4 | Current Alzheimer Research | journal | 1.187 Q2 | 103 | 123 | 378 | 7650 | 1221 | 349 | 3.08 | 62.20 | 41.17 | |
5 | Journal of Obesity | journal | 1.154 Q2 | 66 | 33 | 164 | 1300 | 471 | 157 | 2.45 | 39.39 | 47.93 | |
6 | Journal of Diabetes Research | journal | 1.116 Q2 | 83 | 246 | 767 | 11511 | 2206 | 741 | 2.89 | 46.79 | 46.30 | |
7 | International Journal of Breast Cancer | journal | 1.025 Q2 | 23 | 17 | 51 | 481 | 124 | 51 | 2.17 | 28.29 | 52.08 | |
8 | Current Medicinal Chemistry | journal | 1.015 Q2 | 202 | 284 | 873 | 35541 | 2862 | 815 | 3.32 | 125.14 | 42.59 | |
9 | Cardiovascular Psychiatry and Neurology | journal | 0.997 Q2 | 27 | 2 | 11 | 97 | 32 | 11 | 3.00 | 48.50 | 50.00 | |
10 | Current Molecular Pharmacology | journal | 0.996 Q1 | 49 | 27 | 90 | 2153 | 168 | 75 | 1.90 | 79.74 | 28.00 | |
11 | Current Cancer Drug Targets | journal | 0.951 Q1 | 103 | 69 | 223 | 6431 | 569 | 204 | 2.18 | 93.20 | 44.49 | |
12 | Current Gene Therapy | journal | 0.951 Q1 | 80 | 44 | 140 | 4205 | 309 | 131 | 2.13 | 95.57 | 41.06 | |
13 | Stroke Research and Treatment | journal | 0.932 Q2 | 43 | 19 | 59 | 898 | 160 | 57 | 2.58 | 47.26 | 27.50 | |
14 | Advances in Orthopedics | journal | 0.922 Q1 | 23 | 9 | 75 | 261 | 128 | 73 | 1.63 | 29.00 | 16.95 | |
15 | Current Genomics | journal | 0.922 Q3 | 77 | 47 | 153 | 5193 | 358 | 132 | 2.10 | 110.49 | 35.91 | |
16 | Current Drug Targets | journal | 0.906 Q2 | 119 | 140 | 536 | 14215 | 1303 | 481 | 2.13 | 101.54 | 41.85 | |
17 | Prostate Cancer | journal | 0.890 Q1 | 15 | 3 | 25 | 124 | 65 | 24 | 2.73 | 41.33 | 26.09 | |
18 | Analytical Cellular Pathology | journal | 0.886 Q1 | 35 | 11 | 75 | 553 | 160 | 75 | 2.28 | 50.27 | 34.55 | |
19 | Current Topics in Medicinal Chemistry | journal | 0.885 Q2 | 133 | 262 | 747 | 27685 | 2168 | 649 | 3.09 | 105.67 | 38.41 | |
20 | Current Pharmaceutical Design | journal | 0.883 Q2 | 183 | 620 | 1828 | 74679 | 5143 | 1667 | 2.66 | 120.45 | 41.54 | |
21 | Current Diabetes Reviews | journal | 0.879 Q2 | 68 | 51 | 146 | 4391 | 353 | 133 | 1.90 | 86.10 | 47.37 | |
22 | International Journal of Hepatology | journal | 0.874 Q2 | 20 | 5 | 26 | 151 | 66 | 26 | 2.26 | 30.20 | 53.33 | |
23 | International Journal of Genomics | journal | 0.868 Q1 | 37 | 82 | 166 | 4472 | 443 | 160 | 1.77 | 54.54 | 44.06 | |
24 | Canadian Journal of Gastroenterology and Hepatology | journal | 0.867 Q2 | 76 | 58 | 299 | 1808 | 446 | 233 | 1.33 | 31.17 | 42.81 | |
25 | CNS and Neurological Disorders - Drug Targets | journal | 0.863 Q2 | 96 | 125 | 504 | 9747 | 1140 | 436 | 1.83 | 77.98 | 45.17 | |
26 | Current Protein and Peptide Science | journal | 0.858 Q2 | 96 | 124 | 246 | 11582 | 625 | 209 | 2.27 | 93.40 | 42.57 | |
27 | Open AIDS Journal | journal | 0.845 Q2 | 22 | 13 | 47 | 450 | 77 | 43 | 1.71 | 34.62 | 41.18 | |
28 | Parkinson's Disease | journal | 0.841 Q2 | 59 | 68 | 206 | 3367 | 510 | 201 | 2.51 | 49.51 | 47.75 | |
29 | Journal of Skin Cancer | journal | 0.840 Q1 | 15 | 7 | 26 | 293 | 53 | 25 | 1.65 | 41.86 | 65.00 | |
30 | Depression Research and Treatment | journal | 0.816 Q2 | 36 | 7 | 52 | 281 | 119 | 50 | 1.86 | 40.14 | 31.25 | |
31 | Dermatology Research and Practice | journal | 0.806 Q1 | 38 | 10 | 76 | 328 | 160 | 75 | 1.40 | 32.80 | 51.92 | |
32 | Autoimmune Diseases | journal | 0.805 Q2 | 41 | 3 | 66 | 89 | 153 | 62 | 2.08 | 29.67 | 36.84 | |
33 | Current Cardiology Reviews | journal | 0.793 Q2 | 58 | 36 | 133 | 2397 | 232 | 118 | 1.41 | 66.58 | 23.58 | |
34 | International Journal of Vascular Medicine | journal | 0.782 Q2 | 34 | 12 | 56 | 428 | 128 | 56 | 2.36 | 35.67 | 28.57 | |
35 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.760 Q2 | 52 | 27 | 83 | 3115 | 216 | 78 | 2.43 | 115.37 | 41.11 | |
36 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.742 Q2 | 63 | 39 | 126 | 2195 | 285 | 117 | 1.99 | 56.28 | 47.43 | |
37 | Current Drug Abuse Reviews | journal | 0.716 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
38 | Current Vascular Pharmacology | journal | 0.715 Q2 | 69 | 68 | 292 | 5333 | 555 | 233 | 1.71 | 78.43 | 41.22 | |
39 | Current Neurovascular Research | journal | 0.682 Q3 | 60 | 55 | 138 | 2543 | 253 | 124 | 1.70 | 46.24 | 40.98 | |
40 | Journal of King Saud University, Engineering Sciences | journal | 0.682 Q1 | 55 | 52 | 79 | 1194 | 214 | 76 | 2.77 | 22.96 | 11.00 | |
41 | Journal of Nutrition and Metabolism | journal | 0.681 Q2 | 57 | 42 | 89 | 1752 | 169 | 87 | 1.74 | 41.71 | 52.22 | |
42 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.674 Q2 | 108 | 174 | 488 | 9129 | 1081 | 454 | 2.02 | 52.47 | 43.09 | |
43 | Malaria Research and Treatment | journal | 0.672 Q3 | 22 | 11 | 48 | 366 | 67 | 48 | 0.81 | 33.27 | 33.33 | |
44 | Clinical Practice and Epidemiology in Mental Health | journal | 0.671 Q2 | 58 | 24 | 69 | 1139 | 125 | 68 | 1.49 | 47.46 | 51.16 | |
45 | Anemia | journal | 0.669 Q2 | 31 | 4 | 40 | 114 | 105 | 40 | 2.31 | 28.50 | 29.41 | |
46 | International Journal of Microbiology | journal | 0.662 Q2 | 59 | 45 | 110 | 1720 | 279 | 109 | 2.49 | 38.22 | 43.78 | |
47 | Advances in Hematology | journal | 0.661 Q2 | 38 | 7 | 63 | 301 | 129 | 62 | 2.34 | 43.00 | 55.56 | |
48 | Journal of the Saudi Society of Agricultural Sciences | journal | 0.643 Q1 | 58 | 51 | 73 | 1812 | 219 | 73 | 2.75 | 35.53 | 21.52 | |
49 | Schizophrenia Research and Treatment | journal | 0.640 Q2 | 11 | 5 | 11 | 276 | 24 | 11 | 2.20 | 55.20 | 60.71 | |
50 | Interdisciplinary Perspectives on Infectious Diseases | journal | 0.627 Q2 | 35 | 7 | 59 | 368 | 134 | 59 | 1.35 | 52.57 | 42.31 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®